CLGN - CollPlant Biotechnologies Ltd.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate-0.37-0.37-1.04-0.21
Low estimate-0.41-0.42-1.55-0.89
High estimate-0.33-0.33-0.530.46
Year ago EPS-0.39-0.4-1.53-1.04
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate160k210k5.57M25.79M
Low estimate120k130k930k10.74M
High estimate200k300k10.2M40.84M
Year ago sales66k109k299k5.57M
Sales growth (year/est)142.40%92.70%1,762.90%363.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.08-0.31-0.31-0.29
Actual EPS-0.39-0.4-0.38-0.33
Difference-0.31-0.09-0.07-0.04
Surprise %-387.50%-29.00%-22.60%-13.80%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.37-0.37-1.04-0.21
7 days ago-0.37-0.13-0.67-0.34
30 days ago-0.34-0.1-0.56-0.19
60 days ago-0.34-0.1-0.56-0.19
90 days ago-0.44-0.44-0.090.93
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesCLGNIndustrySector(s)S&P 500
Current qtr.5.10%N/AN/AN/A
Next qtr.7.50%N/AN/AN/A
Current year32.00%N/AN/AN/A
Next year79.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A